Moffitt Notice of Blackbaud Data Incident. Learn More
Your Brain Tumor Specialists
If you are searching for a brain tumor or spinal tumor specialist to provide you with a second opinion or suggest a treatment plan that’s appropriate for your specific diagnosis, visit Moffitt Cancer Center. Our Neuro-Oncology program features physicians from a range of specialties who focus exclusively on the evaluation, diagnosis and treatment of primary and metastasized brain and spinal tumors.
The multispecialty team of Moffitt’s Neuro-Oncology Program includes:
- Medical oncologists
- Radiation oncologists
- Other experts
Our diverse and highly experienced team of specialists provides chemotherapy, radiation therapy, biological therapy, immunotherapy, nuerosurgical procedures and other treatments for brain cancer in one convenient location. Every patient in this program receives an individualized treatment plan that is developed by our Neuro-Oncology tumor board to ensure the best possible outcomes and quality of life.
Moffitt also spearheads research initiatives to better understand the role of genetics in brain tumor growth and develop more effective treatment methods. In fact, our robust clinical trials program allows brain cancer patients to experience the latest breakthroughs in treatment before they are made available elsewhere. Our commitment to cancer research has earned us recognition as a National Cancer Institute-designated Comprehensive Cancer Center – the only one based in Florida.
At Moffitt, we understand that a brain tumor or spinal tumor is more than a disease – it’s an overwhelming diagnosis that warrants emotional support in addition to treatment from a brain and spinal tumor specialist. That’s why we offer a full spectrum of supportive care to patients and their families at the same location as our other treatments. Patients are cared for by counselors, dietitians, social workers and other professionals who can help manage side effects of treatment and disease to improve quality of life.
Medically Reviewed by Dr. Michael Vogelbaum, Program Leader, Department of Neuro-Oncology.